IDBS PIMS
IDBS PIMS is cloud-native, 21 CFR Part 11–compliant manufacturing process intelligence software that creates a contextualized data backbone for critical process and quality data across products and batches. Purpose-built for biopharma manufacturing, PIMS unifies batch monitoring, limits management and analytics — enabling faster CPV reporting, smarter deviation investigations and secure collaboration across captive sites and C…
IDBS PIMS (Process Information Management System) is a cloud-native, 21 CFR Part 11–compliant manufacturing process intelligence platform that gives biopharma manufacturers a single source of truth for critical process and quality data across products, batches, sites and external partners. Designed for all modalities—small molecules, biologics, and cell and gene therapies—PIMS captures, aggregates and contextualizes data from MES, EBR, SCADA, historians, LIMS, QMS and ERP, and turns it into shared, actionable insight for process engineers, MSAT, quality and regulatory teams. With modules for batch monitoring, centralized limits management, advanced analytics, raw materials and stability, PIMS streamlines CPV reporting, accelerates deviation investigations, supports APQR and CMC submissions, and enables secure real-time collaboration across captive sites and CDMO networks.
Early adoption of digital process systems puts you in control
This infographic explores how early adoption of digital process information management systems can strengthen process performance qualification (PPQ) and support successful drug manufacturing scale-up. Learn how IDBS PIMS helps organizations improve process control, maintain data continuity, reduce discrepancies, and streamline technology transfer from development through commercial manufacturing. Discover how a centralized digital data backbone enables better decision-making, faster regulatory readiness, and greater confidence in process performance throughout the product lifecycle.
Resource details:
Resource type: Infographic
Page count: 4
Read time: 6 mins
Smarter drug manufacturing process data management with IDBS PIMS
Explore IDBS PIMS, a process information management system designed to help biopharmaceutical organizations centralize, manage and analyze manufacturing process data. Learn how PIMS provides a single source of truth for product, process, batch, and quality data, enabling greater visibility, regulatory compliance, and operational efficiency. Discover how integrated analytics, secure collaboration, and scalable cloud deployment support faster scale-up, technology transfer, process monitoring, and business reporting across the drug development lifecycle.
Resource details:
Resource type: Infographic
Page count: 6
Read time: 8 mins
Submission readiness is built, not reconstructed: Connecting CMC knowledge for Module 3
Monday, November 2 at 16:00 GMT | 17:00 CET | 11:00 EST | 08:00 PST
Why do chemistry, manufacturing and controls (CMC) and regulatory teams still spend significant time searching for evidence, validating historical decisions, and reconstructing the scientific rationale behind established processes?
The problem is rarely a complete absence of data. More often, the connections between product requirements, experiments, risk assessments, process parameters and scientific decisions have weakened as information moves through development, scale-up and technology transfer. By the time Module 3 preparation begins, teams may be able to find the final value without being able to readily recover why it was selected or how it was justified.
In this SelectScience® webinar, Ken Forman, Lead Product Manager at IDBS, and Mark Buswell, Director of AMB Engineering and Technology and former Vice President at GSK, will explore how organizations can make submission readiness an outcome of the development process rather than a retrospective evidence-reconstruction exercise.
Drawing on experience spanning preclinical research, analytical development and global system implementation, the speakers will examine where valuable knowledge and scientific context are most at risk across the product lifecycle. They will also discuss which connections need to remain intact so that teams can prepare Module 3 documentation and clearly explain why established processes and parameters were selected.
By attending this webinar, you will gain practical insights into strengthening continuity across CMC, maintaining traceability between scientific evidence and decisions, and making submission evidence easier to reuse, interpret and defend.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
Cost: Free to attend
Location: Online
Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.











